The mission of the Schizophrenia International Research Society (SIRS) is to be a worldwide organization that aims to bring together researchers and clinicians in schizophrenia and related disorders.
SIRS membership provides the opportunity to join and network with fellow scientists from around the world to exchange the latest advances in biological and psychosocial research in schizophrenia. Your SIRS membership benefits your career as well as your profession — an invaluable investment in your future. Join the recognized leader in promoting schizophrenia research.
SIRS is committed to providing a forum for the exchange of scientific information, which is critical for the advancement and translation of scientific discovery in schizophrenia and related disorders. SIRS provides the opportunity to stay current on the latest in schizophrenia research through our partnerships with npj Schizophrenia (SIRS official journal), Schizophrenia Bulletin and Schizophrenia Research.
In order to further our mission of bringing together researchers in schizophrenia and related disorders, philanthropic gifts are needed to positively impact the field through research and clinical application. All gifts are important whether $50, $200, $2,000 or any size - they all are meaningful and needed to fuel the continued growth, development and advancement of schizophrenia research.
We are excited to invite you to participate in the 2022 Congress of the Schizophrenia International Research Society (SIRS) to be held in a hybrid format in Florence, Italy on 6-10
April 2022. SIRS 2021 Virtual Conference attracted nearly 1000 researchers from 51 countries. We hope you will help us make the 2022 Congress a success. This year’s theme is Moving Forward Together: Diversity in Global Research.
The Program Committee is now requesting proposals for the following presentations:
Oral/Poster Deadline: 7 December 2021
Pharmaceutical Pipeline Deadline: 18 January 2022
Please click here to read the full submission guidelines.
The Education Committee is now requesting applications for the following:
Early Career Awards: Deadline 7 December 2021
Learn more about the SIRS Early Career Award program by clicking here. Are you an Early Career Researcher from an underrepresented country? SIRS is now offering the opportunity to have your oral or poster abstract reviewed prior to the poster/oral abstract submission deadline for the 2022 Congress. CLICK HERE to learn more!
The Awards Committee is now requesting nominations for the following:
Honorific Awards: Deadline 7 December 2021
Global Schizophrenia Award: Deadline 7 December 2021
The individual and nominator must be current SIRS members. Click here to to view the award details and submission requirements.
♦ SIRS has awarded the 2021 Research Harmonisation Award to the convener Sandra Bucci, Ph.D. from the University of Manchester. See the full announcement
♦ The 2021 Congress plenary recordings and Diversity Task Force Workshop are now available on the SIRS website! To access the recordings, follow this link
♦ SIRS Introduces the 2021-2025 Strategic Plan
♦ npj Schizophrenia Receives receives an Impact Factor of 5.200
Listen as SIRS Secretary, Paola Dazzan, chats with Gemma Modinos about the value of SIRS membership. Be sure to watch what other SIRS members are saying about their experience with the society.
SIRS is excited to announce the 2022 Congress keynote and plenary speakers. We wish to showcase excellent global research into psychosis and show how we can use this knowledge to benefit individuals with serious mental health diagnoses and their families. There will be multiple plenary sessions, symposia sessions, workshops and oral and poster presentations submitted by international researchers on a variety of timely topics at the hybrid 2022 Congress in Florence, Italy on 6-10 April 2022.
Check out our highlighted sessions section for more information about our keynote, Cecelia McGough, and the plenary speakers at https://schizophreniaresearchsociety.org/meetings/highlighted-sessions/.
Over more than 30 years, I have been involved in studying the genetic background of schizophrenia. My undergraduate training background is in pharmaceutical chemistry. In 1989, I was offered a PhD scholarship in a lab in Munich, Germany, with a focus to build up genetic analyses in families with schizophrenia. The idea, which actually hasn’t changed that much since then, was to identify altered genes which then can be used for developing novel treatments, targeting the real causes of schizophrenia.
The decision, to join this lab challenged my previous discipline focussed understanding of academic research. Early on, I realized that discussion with psychiatrists, psychologists, statisticians, geneticists, counsellors, social workers, and many other disciplines, which I have not even thought of, can only happen in a meaningful way, when one actively engages with their views on the research. Since the field was only starting to building up momentum, there were not many societies around which would help with this cross-disciplinary development. Some winter workshops were available, which I would count as precursor to what then finally developed into the Schizophrenia International Research Society in 2005. I joined the Society in 2008, presenting in a debate forum at the first Schizophrenia International Research Society Conference. I believe that the Society has provided a home for my desire to engage more broadly with related disciplines. In contrast to other, genetically focussed meetings, I enjoy the breadth and depth of knowledge, which is disseminated during their meetings. I enjoy the discussions, which happened not only during poster sessions, but also during panel discussions and workshops. Retrospectively, I have to say that the breadth and interdisciplinary nature of these conferences, the opportunity to being inspired by achievements out of my initial focus, more recently the educational resources and online resources available, embraces the value of being a member of this society. This is also the reason, why I happily decided to support the Society’s endeavours in joining the International Advisory Board Committee, being involved with the travel awards selection committees (even these generally happen to be around Christmas) and more recently, being a member of the Membership Committee, which I am now chairing since 2020. Having had the opportunity to see this Society grow since its inception, I feel honoured to be connected and involved with such a varied, diverse and vibrant community. The only thing which I miss was that the Society was not yet available, when I started my journey in schizophrenia genetics when starting my PhD.